Author Profile

Written By

Shannon Epling

Content Manager, CAS

Shannon is a 15-year employee and member of the American Chemical Society. She is a manager in the Life Sciences division at CAS. She earned an M.S. in Pharmaceutical Sciences from the University of Florida and is currently finishing a doctoral degree in Instructional Design Leadership. She is a founding member of the Coronavirus Task Force established at CAS in February 2020, which continues to escalate COVID-19–related content for CAS products and customers. 

Latest Content from Shannon Epling

cannabinoid compounds as potential therapeutics

January 25, 2022

The scientific trends of cannabinoid research

This blog is focused on lesser-known cannabinoids, their key medicinal benefits discussed in the scientific literature, and a deeper view into their chemical structures.

Coronavirus Variants of Concern thumbnail

July 6, 2021

Coronavirus Variants: The Delta Variant and the Future Impact of Viral Mutations

If you are fully vaccinated, should you be worried about the impact of COVID-19 variants? Read this blog and learn about effectiveness of vaccines on Coronavirus variants.

Pfizer Covid Vaccine approved for 12-15 year olds

May 10, 2021

Latest data on the safety and effectiveness of COVID-19 vaccines in children

Information covering CDC recommendation of pediatric COVID-19 vaccine for children ages 5-11, and original emergency use authorization from May 2021 for children 12-15.

March 24, 2021

The Latest COVID-19 Vaccine Questions Answered

Answers to frequently asked questions regarding the safety, efficacy, and composition of the currently available Covid vaccines. Updated March 26, 2021.